Literature DB >> 1833947

Postural control in Huntington's disease (HD).

J R Tian1, S J Herdman, D S Zee, S E Folstein.   

Abstract

We studied postural control, using quantitative moving-platform posturography, in 20 patients with Huntington's Disease (HD) and in 20 age-matched controls. HD patients showed considerably more anterior-posterior sway than normals, even when a correction for chorea was attempted. This increase in sway was especially true when, by eliminating visual and by attenuating proprioceptive cues, patients were forced to rely primarily on vestibular cues for balance. HD patients also showed increased latencies (30-50 ms) but normal amplitude, in response to translational perturbations of the platform. HD patients showed increased amplitude of responses to rotational perturbations of the platform but a normal decrease in response on successive trials. Thus, patients with HD show a consistent pattern of abnormality on posturography suggesting a role for the basal ganglia in a number of aspects of postural control.

Entities:  

Mesh:

Year:  1991        PMID: 1833947     DOI: 10.3109/00016489109131415

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.

Authors:  Florian Lipsmeier; Cedric Simillion; Atieh Bamdadian; Rosanna Tortelli; Lauren M Byrne; Yan-Ping Zhang; Detlef Wolf; Anne V Smith; Christian Czech; Christian Gossens; Patrick Weydt; Scott A Schobel; Filipe B Rodrigues; Edward J Wild; Michael Lindemann
Journal:  J Med Internet Res       Date:  2022-06-28       Impact factor: 7.076

2.  The impact of different types of assistive devices on gait measures and safety in Huntington's disease.

Authors:  Anne D Kloos; Deborah A Kegelmeyer; Susan E White; Sandra K Kostyk
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

3.  Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study.

Authors:  Marcus P J van Diemen; Ellen P Hart; Anthony Abbruscato; Liz Mead; Ilse van Beelen; Sandrin C Bergheanu; Pieter W Hameeteman; Emma Coppen; Jessica Y Winder; Matthijs Moerland; Hermien Kan; Jeroen van der Grond; Andrew Webb; Raymund A C Roos; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2020-12-29       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.